Prognostic value of class III b-tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin-based chemotherapy (CT): A validation study on three randomized trials

被引：3
|
作者：
Reiman, T.
Seve, P.
Vataire, A.
Dunant, A.
Rosell, R.
Graziano, S.
Seymour, L.
Pirker, R.
Lai, R.
机构：
[1] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[2] Univ Lyon 1, Hosp Civils Lyon, F-69365 Lyon, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Catalan Inst Oncol, Barcelona, Spain
[5] SUNY Syracuse, Syracuse, NY USA
[6] Queens Univ, Kingston, ON, Canada
[7] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.7506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7506
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Validation of the prognostic and predictive value of class III beta tubulin (TUBB3) for adjuvant chemotherapy (ACT) in completely resected non-small cell lung cancer (R-NSCLC): results from four randomized trials
    Reiman, Tony
    Seve, Pascal
    Veillard, Anne-Sophie
    Soria, Jean-Charles
    Rosell, Rafael
    Taron, Miquel
    Graziano, Stephen
    Kratzke, Robert
    Seymour, Lesley
    Shepherd, Frances
    Pignon, Jean-Pierre
    Lai, Raymond
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S298 - S298
  • [2] Results of the Randomized International Adjuvant Lung Cancer Trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC).
    Le Chevalier, T
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 238S - 238S
  • [3] A pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small cell lung cancer (NSCLC)
    Fruh, M.
    Tribodet, H.
    Pignon, J.
    Winton, T.
    Le Chevalier, T.
    Scagliotti, G. V.
    Douillard, J. Y.
    Seymour, L.
    Spiro, S. G.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Class III β-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer:: Analysis of NCIC JBR.10
    Seve, Pascal
    Lai, Raymond
    Ding, Keyue
    Winton, Timothy
    Butts, Charles
    Mackey, John
    Dumontet, Charles
    Dabbagh, Laith
    Aviel-Ronen, Sarit
    Seymour, Lesley
    Whitehead, Marlo
    Tsao, Ming-Sound
    Shepherd, Frances A.
    Reiman, Tony
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 994 - 999
  • [5] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [6] Predictive value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with chemotherapy (CT)
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Mellema, Wouter
    Heideman, Danielle
    Van Suylen, Robertjan
    Thunnissen, Erik
    CANCER RESEARCH, 2011, 71
  • [7] Long-term results of the International Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin-based chemotherapy in resected non-small cell lung cancer (NSCLC)
    Le Chevalier, T.
    Dunant, A.
    Arriagada, R.
    Bergman, B.
    Chabowski, M.
    LePechoux, C.
    Kozlowski, M.
    Tarayre, M.
    Pignon, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study
    Huang, Zhi-Liang
    Cao, Xun
    Luo, Ruo-Zhen
    Chen, You-Fang
    Zhu, Lin-Chun
    Wen, Zhesheng
    ONCOLOGY LETTERS, 2016, 11 (01) : 299 - 305
  • [9] Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients with Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
    Yong, L.
    Kuo, S.
    Yang, P.
    Huang, P.
    Lin, M.
    Chen, K.
    Lee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S708 - S708
  • [10] Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials
    Petrelli, Fausto
    Barni, Sandro
    MEDICAL ONCOLOGY, 2013, 30 (03)
12345